We offer superior dental care to residents of Calgary and nearby areas in Alberta, with a focus on improving their smiles.
Menopause is a natural part of a woman’s life, and some women may be concerned about developing osteoporosis. As a result, they may consult their doctor for advice on preventing this condition.
Historically, various medications have been prescribed to treat bone diseases, with bisphosphonates being the preferred choice in recent years. Bisphosphonates, such as Floramax, Boniva, Actonel, Didronel, and Reclast, have been shown to be highly effective in maintaining bone density in postmenopausal women, as well as in treating conditions like Paget’s Disease and certain forms of cancer. However, like all drugs, bisphosphonates can have side effects, especially if taken over extended periods of time.
Bisphosphonates work by affecting osteoblasts and osteoclasts, the bone cells responsible for dissolving bone tissue. This slows or stops the natural process of bone resorption, leading to maintained or increased bone density. It is crucial to understand the possible side effects of these drugs, particularly when they are taken on a long-term basis. One potential risk associated with bisphosphonate use is the development of osteonecrosis of the jaw, a condition in which the jawbone begins to die.
It is important to note that the risk of developing osteonecrosis of the jaw is low for patients who take bisphosphonates in pill form. Nevertheless, this risk is of concern to dentists, as it can affect the success of oral surgery, tooth extractions, gum and bone disease treatment, dental implant procedures, and root canals. Prevention is the best approach to managing this risk. Patients who are taking bisphosphonates should inform their dentist of their medication use so that they can receive appropriate dental care.
If you anticipate taking a Bisphosphonates drug soon or are already taking one, please contact our office for a comprehensive dental examination. We can identify and treat any existing oral health conditions early to minimize the risk of developing osteonecrosis of the jaw.
